A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-63733657 in Healthy Subjects and Subjects With Alzheimer's Disease
Clinical trial NCT03375697 · COMPLETED
Trial details
- NCT number
- NCT03375697
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-22
- Primary completion
- 2019-12-16
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.